ID: ALA5075247

Max Phase: Preclinical

Molecular Formula: C16H17NO2

Molecular Weight: 255.32

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  C#CCOc1ccc(-c2c(N(CC)CC)c2=O)cc1

Standard InChI:  InChI=1S/C16H17NO2/c1-4-11-19-13-9-7-12(8-10-13)14-15(16(14)18)17(5-2)6-3/h1,7-10H,5-6,11H2,2-3H3

Standard InChI Key:  DWRNAAAESCHVMC-UHFFFAOYSA-N

Associated Targets(Human)

Bcap37 715 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 255.32Molecular Weight (Monoisotopic): 255.1259AlogP: 2.45#Rotatable Bonds: 6
Polar Surface Area: 29.54Molecular Species: NEUTRALHBA: 3HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: 2.62CX LogD: 2.62
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.74Np Likeness Score: -0.91

References

1. Fan Y, Si H, Zhang Z, Zhong L, Sun H, Zhu C, Yin Z, Li H, Tang G, Yao SQ, Sun P, Zhang ZM, Ding K, Li Z..  (2021)  Novel Electrophilic Warhead Targeting a Triple-Negative Breast Cancer Driver in Live Cells Revealed by "Inverse Drug Discovery".,  64  (21.0): [PMID:34623802] [10.1021/acs.jmedchem.0c02024]

Source